MOL CELL 润色咨询

MOLECULAR CELL

出版年份：1997 年文章数：5394 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：3.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2023-09-04 ms9508293866653270 来自陕西省

    审稿速度:2.0
    经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2022-04-09 tomsyu

    有人发过这个杂志吗？把投稿状态分享一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2021-11-22 linkends353

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向：代谢;肿瘤
    经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2019-11-30 bigapple001

    本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2017-03-14 shudilaodao

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2016-08-17 ms8200391780771680

    审稿速度:2.0
    经验分享：data presentation image screening 哪位同仁知道这是什么意思？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2016-05-07 rightherely

    data presentation image screening 哪位同仁知道这是什么意思？

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2015-06-22 princesun083

    6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2014-07-05 匿名用户

    毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell.

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2155972, encodeId=ddee21559e214, content=审稿速度:2.0<br>经验分享：这个杂志几乎没有水文，非常认可，我觉得和NCB差不多，偏重代谢领域，发一篇，基金基本不愁了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Mon Sep 04 08:31:43 CST 2023, time=2023-09-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209717, encodeId=38701209e174a, content=有人发过这个杂志吗？把投稿状态分享一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Sat Apr 09 06:44:17 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072788, encodeId=216c10e27883a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向：代谢;肿瘤<br>经验分享：第一篇应该是最难的，发顺了的话也不难，新机制与代谢相关的容易发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45c65457430, createdName=linkends353, createdTime=Mon Nov 22 10:58:51 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580720, encodeId=e8e2580e2090, content=本土学者很难发这个期刊，但是随着越来越多海外老师的引进，mc在国内发得也越来越多。需要严谨的机制解释，不然很难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sat Nov 30 00:00:00 CST 2019, time=2019-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534211, encodeId=72ba53421109, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：审稿快，不到一个月就出结果，水平要求高，新颖性是必须的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=568, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170314/IMG58C7CA05C268E1697.jpg, createdBy=adfa81085, createdName=shudilaodao, createdTime=Tue Mar 14 18:42:00 CST 2017, time=2017-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833119, encodeId=003c83311930, content=审稿速度:2.0<br>经验分享：data presentation image screening 哪位同仁知道这是什么意思？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3755414116, createdName=ms8200391780771680, createdTime=Wed Aug 17 14:38:49 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522108, encodeId=3215522108a0, content=data presentation image screening 哪位同仁知道这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4951630181, createdName=rightherely, createdTime=Sat May 07 16:32:00 CST 2016, time=2016-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512852, encodeId=7efa51285279, content=6月8日投稿一篇，结果只撑了13天...难啊，说需要有开拓性的研究成果，创新性要求太高了。下次再战！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150826/IMG55DD4550988EA1332.jpg, createdBy=3f88101689, createdName=princesun083, createdTime=Mon Jun 22 18:10:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503942, encodeId=f15a50394237, content=毕竟是cell 系列的，没有比较好的结果最好不要投。虽然比不了 cell和cancer cell., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=463, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 05 10:22:00 CST 2014, time=2014-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502465, encodeId=eeb150246541, content=SCI(2012)： 15.28 <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=782, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 22 18:54:00 CST 2014, time=2014-04-22, status=1, ipAttribution=)]
    2014-04-22 匿名用户

    SCI(2012)： 15.28

    0

共40条页码: 2/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分